Oral Probiotic Delivering GLP-1 Restores Pancreatic Function and Gut Barrier in Diabetic Mice | Research

The takeaway

Recombinant L. lactis secreting GLP-1 analogue restored pancreatic β-cell mass, improved insulin secretion, repaired gut barrier, and modulated microbiota in T2D mice through oral delivery.

Living GLP-1 factory
An engineered probiotic bacteria produces and delivers GLP-1 directly in the gut — potentially replacing expensive injectable drugs with an oral probiotic

What the researchers found

Recombinant L. lactis secreting GLP-1 analogue: restored β-cell mass and insulin secretion, improved glucose tolerance, repaired gut barrier (tight junctions), and beneficially modulated gut microbiota in T2D mice.

Why it matters

Injectable GLP-1 drugs are expensive and inconvenient. A probiotic delivering GLP-1 orally could democratize access to this transformative therapy.

How the study worked

Engineering of L. lactis for GLP-1 analogue secretion, oral administration to T2D mice, glucose tolerance testing, pancreatic histology/β-cell assessment, gut barrier integrity markers, and microbiota analysis.

What this study cannot tell us

Mouse model. GLP-1 levels from probiotic delivery may be lower than injectable. Long-term colonization and consistent GLP-1 production not guaranteed.

How to read the evidence

Preclinical with comprehensive mechanistic validation. Novel delivery platform.

When this study was published

Published in 2025.

The bigger picture

Probiotic-delivered peptide therapy represents a fundamentally new drug delivery paradigm — living factories producing medicine in the gut.

Questions still open

Could this probiotic replace injectable GLP-1 drugs in humans?
How long does the probiotic colonize and produce GLP-1?
Would this approach work for other therapeutic peptides?

Common questions

Could a probiotic replace GLP-1 injections?

In mice, an engineered probiotic producing GLP-1 in the gut improved diabetes, restored pancreatic cells, and fixed gut barrier — all from oral delivery. Human translation is the next challenge.

How does a probiotic deliver a drug?

The bacteria are genetically programmed to produce and secrete the GLP-1 peptide as they colonize the gut. They become tiny drug factories living inside the intestine.

Read the original research

Oral delivery of GLP-1 analogues by recombinant Lactococcus lactis restores pancreatic islet structure through intestinal mucosal absorption in diabetic mice.

EBioMedicine, 124, 106141

View on PubMed ↗Publisher’s paper ↗

Citation

Huang, Yuanjian; Lin, Xuancai; Deng, Min; Tang, Yanqing; Li, Simin; Xu, Binyan; Zeng, Weixing; Chen, Zerong; Hou, Xufeng; Lin, Ziqing; Meng, Xiaojing; Bai, Yang; Fan, Hongying; Zeng, Weisen. (2026). Oral delivery of GLP-1 analogues by recombinant Lactococcus lactis restores pancreatic islet structure through intestinal mucosal absorption in diabetic mice.. EBioMedicine, 124, 106141. https://doi.org/10.1016/j.ebiom.2026.106141